The study was published in Proceedings of the National Academy of Sciences on March 4, 2026, and was funded by federal research grants from the National Institutes of Health and private philanthropy
One proposal is that hypofunction of NMDA receptors (NMDAR) located on inhibitory GABA inter-neurons leads to reduced activity of these inter-neurons, resulting in increased pyramidal glutamatergic neurotransmission and the diverse symptoms occurring in acute psychosis [3]
A separate MDL was also established in December 2025 specifically for patients who experienced vision loss (NAION) after taking a GLP-1 drug, with dozens of cases already filed and more expected
Anti-inflammatory potential of curcumin and quercetin in rats: role of oxidative stress, heme oxygenase-1 and TNF-alpha
According to the FDA, these containers are made of puncture-resistant plastic for a reason
Never miss another update on the newest regulations, court decisions, state laws and trends in the field.
